Items tagged with Access
250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries (post)
Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens to seven countries to help prevent tuberculosis (TB). The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes.
Ukraine’s fight against TB (post)
To mark World TB Day (24 March), EURACTIV talked with two Ukrainians about how Ukrainians are fighting not only Russia’s invasion but also one of the highest incidences of TB cases in the European region - Andriy Klepikov, Executive Director of the Alliance for Public Health, and Anton Basenko, Programme Manager at European AIDS Treatment Group (EATG), Ukrainian civil society representative and TB survivor.
How push from survivors and an HIV support group led to a cheaper TB drug (post)
Advocacy by patients led authorities to reject a patent application for bedaquiline, a drug that shortens treatment and has a higher success rate.
Publication demonstrates how equitable deals for access to medicines can be signed with pharmaceutical industry (post)
12 Apr 2023 — A new article published today by the Oxford University Press Journal of Intellectual Property Law and Practice shows how fair deals on medical research that ensure equitable access to life-saving medicines can be signed with pharmaceutical companies.
WHO BPaLM Accelerator Platform: to support the Call to Action for implementation of the shorter and more effective treatment for all people suffering from drug-resistant TB (post)
The World Health Organization (WHO)’s latest guidelines on drug-resistant TB treatment recommend rapid roll-out of the novel BPaLM regimen that has the potential to dramatically increase cure rates due to its high efficacy, allow broader access due to its lower cost and improve patient quality of life as this regimen is all-oral and significantly shorter than conventional treatment regimens. WHO and its partners have recently issued a Call to Action to call on governments and other stakeholders to accelerate the implementation of the novel, 6-month all-oral regimen for the treatment of drug-resistant TB.
MSF welcomes passage of World Health Assembly resolution to help increase access to disease testing (post)
NEW YORK/GENEVA, MAY 26, 2023 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes today’s passage of a resolution at the 76th annual United Nations World Health Assembly to strengthen countries’ diagnostic testing capacity. With almost half of the global population having little or no access to disease testing, this resolution is an essential step towards improving global access to diagnostic tools, said MSF. Increasing access to testing for a variety of diseases is critical as it is necessary in order to put people on the best medical treatments possible.
Achieving universal access to rapid tuberculosis diagnostics (post)
An editorial in BMJ Global Health reflects on the way to achieve universal access to rapid TB diagnostics and universal drug susceptibility testing.
The ABC for a TB Activist: 1/4/6×24 Campaign and supportive diagnostics (post)
On 15 June, 2023, TB Europe Coalition (TBEC) organized a webinar featuring a presentation by Treatment Action Group’s TB Project Officer, David Branigan, on the practical actions advocates can take to promote the adoption and scale up of shorter, safer 1/4/6 regimens for TB prevention and the treatment of drug-sensitive and drug-resistant TB as well as supportive diagnostics. The webinar discusses specific advocacy strategies to ensure these regimens and diagnostics are included in Global Fund proposals as well as in National Strategic Plans, to promote increased availability and access in countries. This webinar is part of the TBEC webinar series: The ABC for a TB Activist.
Hope away from home: Providing support for refugees with TB, wherever they live (post)
Worldwide, more people are on the move than ever before, with an estimated 103 million forcibly displaced people globally including an estimated 32.5 million refugees. Refugees and other populations in humanitarian settings face considerable threats to their health, wellbeing and survival, including crowded living conditions, poverty, undernutrition, precarious legal status, discrimination and poor access to health and social protection services, all conditions in which tuberculosis (TB) thrives. In most settings, refugees are more likely to be exposed to TB, develop TB disease once exposed and have poor health, social and economic outcomes as a result of it.
Webinar: Shortened TB regimen implementation challenges, and the 1/4/6x24 Campaign (post)
Socios En Salud Centro de Salud Global and partners will host a webinar on 3 August 2023 highlighting the 1/4/6x24 Campaign, examining the experience of the Dominican Republic in rolling out WHO-recommended shorter TB preventive therapy and treatment regimens, with perspectives from the World Health Organization (WHO), the Ministry of Health, civil society, and Dr. Carole Mitnick presenting on the 1/4/6x24 Campaign. The webinar will be offered with Spanish-English simultaneous interpretation.
Page 49 of 83 · Total posts: 0
←First 48 49 50 Last→